Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Manuela Pirovano

12 publications found

Original articles

Pappadà G, Cesana C, Pirovano M, Vergani F, Parolin M, Pirillo D, Pirola E, Santoro P, Ferrarese C, Sganzerla E (2009)
Venous outflow as a criterion of impairment of cerebral vascular reserve
J Neurosurg Sci, 53 (3), 101-5
PubMed 20075821

Alseth I, Eide L, Pirovano M, Rognes T, Seeberg E, Bjørås M (1999)
The Saccharomyces cerevisiae homologues of endonuclease III from Escherichia coli, Ntg1 and Ntg2, are both required for efficient repair of spontaneous and induced oxidative DNA damage in yeast
Mol Cell Biol, 19 (5), 3779-87
DOI 10.1128/MCB.19.5.3779, PubMed 10207101

Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, Petrella V, Barni S, Zecca E, Scarpi E, Labianca R, Amadori D, Luporini G (1999)
A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care
J Pain Symptom Manage, 17 (4), 231-9
DOI 10.1016/s0885-3924(98)00145-6, PubMed 10203875

Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C, Monti M, Arnoldi E, Piva L, Ravaioli A, Cruciani G, Labianca R, Amadori D (1999)
Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care
J Pain Symptom Manage, 17 (4), 240-7
DOI 10.1016/s0885-3924(98)00146-8, PubMed 10203876

Cascinu S, Frontini L, Comella G, Barni S, Labianca R, Battelli N, Casaretti R, Zonato S, Pirovano M, Catalano G, Cellerino R (1999)
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Br J Cancer, 79 (3-4), 491-4
DOI 10.1038/sj.bjc.6690076, PubMed 10027318

Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio A, Terzoli E, Luzzani M, De Marinis F, Caraceni A, Labianca R (1997)
Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care
J Pain Symptom Manage, 13 (1), 1-9
DOI 10.1016/s0885-3924(96)00265-5, PubMed 9029856

Eide L, Bjørås M, Pirovano M, Alseth I, Berdal KG, Seeberg E (1996)
Base excision of oxidative purine and pyrimidine DNA damage in Saccharomyces cerevisiae by a DNA glycosylase with sequence similarity to endonuclease III from Escherichia coli
Proc Natl Acad Sci U S A, 93 (20), 10735-40
DOI 10.1073/pnas.93.20.10735, PubMed 8855249

Zaniboni A, Labianca R, Martignoni G, Barni S, Vinci M, Vaghi M, Pirovano M, Facendola G, Marini G, Luporini G (1996)
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD study
J Chemother, 8 (1), 82-4
DOI 10.1179/joc.1996.8.1.82, PubMed 8835115

Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D (1995)
Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study
Cancer, 75 (10), 2613-22
DOI 10.1002/1097-0142(19950515)75:10<2613::aid-cncr2820751032>3.0.co;2-1, PubMed 7537625

Review articles

Labianca R, Pessi A, Facendola G, Pirovano M, Luporini G (1996)
Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies
Eur J Cancer, 32A Suppl 5, S7-12
DOI 10.1016/s0959-8049(96)00330-9, PubMed 8958036

Zamparelli G, Pancera G, Pessi MA, Dallavalle G, Pirovano M, Valsecchi R, Labianca R, Samori G, Luporini G (1996)
[Locoregional chemotherapy of liver metastasis from colorectal carcinoma]
Ann Ital Chir, 67 (6), 793-7
PubMed 9214270

Other articles

Maltoni M, Pirovano M, Nanni O, Scarpi E (1996)
Studies signaling the prognostic factors of terminally ill phases
J Pain Symptom Manage, 12 (4), 205
DOI 10.1016/0885-3924(96)00143-1, PubMed 8898499

0.12s